251 – 260 of 306
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Lack of Accuracy for the Proposed 'Dubois Criteria' in Alzheimer's Disease: A Validation Study from the Swedish Brain Power Initiative
(
- Contribution to journal › Article
-
Mark
No Association of VEGF Polymorphims with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cystatin C Levels are Positively Correlated with both A beta(42) and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
(
- Contribution to journal › Article
-
Mark
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
(
- Contribution to journal › Article
- 2009
-
Mark
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide
(
- Contribution to journal › Article
-
Mark
Binding and Uptake of A beta 1-42 by Primary Human Astrocytes In Vitro
(
- Contribution to journal › Article
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
(
- Contribution to journal › Article
-
Mark
Long-term rivastigmine treatment in a routine clinical setting.
(
- Contribution to journal › Article